Jean Luc M Lemercier Edwards Lifesciences Corp (EW) insider trading activity

Jean Luc M Lemercier is CVP, EMEACLA and JAPAC of Edwards Lifesciences Corp. Currently has a direct ownership of 184,685 shares of EW, which is worth approximately $12.5 Million. The most recent transaction as insider was on Mar 08, 2023, when has been sold 6,640 shares (Common Stock) at a price of $35.2 per share, resulting in proceeds of $233,728. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 185K

0% 3M change

6.4% 12M change

Total Value Held $12.5 Million

Jean-Luc M Lemercier Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 08 2023	BUY Exercise of conversion of derivative security	$233,728 $35.2 p/Share	6,640 Added 3.65%	175,514 Common Stock
Jul 07 2022	BUY Grant, award, or other acquisition	-	6,100 Added 3.49%	168,874 Common Stock
May 17 2022	SELL Payment of exercise price or tax liability	$13,718 $95.93 p/Share	143 Reduced 0.09%	162,756 Common Stock
May 09 2022	SELL Open market or private sale	$1,135,654 $98.24 p/Share	11,560 Reduced 6.63%	162,899 Common Stock
May 09 2022	BUY Exercise of conversion of derivative security	$251,546 $21.76 p/Share	11,560 Added 6.21%	174,459 Common Stock
May 08 2022	SELL Payment of exercise price or tax liability	$61,820 $100.52 p/Share	615 Reduced 0.38%	162,899 Common Stock
May 08 2022	BUY Exercise of conversion of derivative security	-	8,531 Added 4.96%	163,514 Common Stock
May 07 2022	SELL Payment of exercise price or tax liability	$5,127 $100.52 p/Share	51 Reduced 0.03%	154,983 Common Stock
May 04 2022	SELL Payment of exercise price or tax liability	$4,449 $105.93 p/Share	42 Reduced 0.03%	155,034 Common Stock
May 03 2022	BUY Grant, award, or other acquisition	-	2,750 Added 1.74%	155,076 Common Stock
Apr 08 2022	SELL Open market or private sale	$1,439,194 $123.43 p/Share	11,660 Reduced 7.11%	152,326 Common Stock
Apr 08 2022	BUY Exercise of conversion of derivative security	$253,722 $21.76 p/Share	11,660 Added 6.64%	163,986 Common Stock
Mar 11 2022	SELL Open market or private sale	$1,236,660 $106.06 p/Share	11,660 Reduced 7.12%	152,103 Common Stock
Mar 11 2022	BUY Exercise of conversion of derivative security	$253,722 $21.76 p/Share	11,660 Added 6.65%	163,763 Common Stock
Nov 29 2021	SELL Open market or private sale	$11,058 $110.58 p/Share	100 Reduced 0.07%	152,103 Common Stock
Nov 29 2021	BUY Exercise of conversion of derivative security	$2,176 $21.76 p/Share	100 Added 0.07%	152,203 Common Stock
May 17 2021	SELL Payment of exercise price or tax liability	$68,549 $89.49 p/Share	766 Reduced 0.5%	152,062 Common Stock
May 17 2021	BUY Exercise of conversion of derivative security	-	10,631 Added 6.5%	152,828 Common Stock
May 11 2021	SELL Payment of exercise price or tax liability	$12,927 $90.4 p/Share	143 Reduced 0.1%	142,197 Common Stock
May 07 2021	SELL Payment of exercise price or tax liability	$4,679 $91.75 p/Share	51 Reduced 0.04%	142,340 Common Stock
May 04 2021	BUY Grant, award, or other acquisition	-	2,850 Added 1.96%	142,391 Common Stock
Apr 01 2021	SELL Open market or private sale	$1,089,253 $83.66 p/Share	13,020 Reduced 8.53%	139,541 Common Stock
Apr 01 2021	BUY Exercise of conversion of derivative security	$182,020 $13.98 p/Share	13,020 Added 7.86%	152,561 Common Stock
Mar 01 2021	SELL Open market or private sale	$1,104,747 $84.85 p/Share	13,020 Reduced 8.55%	139,220 Common Stock
Mar 01 2021	BUY Exercise of conversion of derivative security	$182,020 $13.98 p/Share	13,020 Added 7.88%	152,240 Common Stock

JML

Jean Luc M Lemercier

CVP, EMEACLA and JAPAC

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EW shares.

Notify only if

Value

Insider Trading

Get notified when an Edwards Lifesciences Corp insider buys or sells EW shares.

Notify only if

Operation

Value

Type

News

Receive news related to Edwards Lifesciences Corp

Track Activities on EW

Account